Evidence map›Paper›PMID 25621807›Full record

ArticleBone marrow transplantation2015

Superior efficacy but higher cost of plerixafor and abbreviated-course G-CSF for mobilizing hematopoietic progenitor cells (HPC) in AL amyloidosis.

B Dhakal, A D'Souza, C Arce-Lara, M Pasquini, W Saber, F Falvo, J Esselman, K Zellner, T Fenske, P N Hari and 1 more

Abstract readComparative StudyLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

B DhakalDivision of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
A D'SouzaDivision of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
C Arce-LaraDivision of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
M PasquiniDivision of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
W SaberDivision of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
F FalvoDivision of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
J EsselmanDivision of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
K ZellnerDivision of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
T FenskeDivision of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
P N HariDivision of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
M HamadaniDivision of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
Medical College of Wisconsin · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AmyloidosisGranulocyte Colony-Stimulating FactorHematopoietic Stem CellsHeterocyclic CompoundsBenzylaminesCosts and Cost AnalysisCyclamsFemaleHematopoietic Stem Cell MobilizationHumansMaleRetrospective StudiesBenzylaminesCyclamsGranulocyte Colony-Stimulating FactorHeterocyclic Compoundsplerixafor

Identifiers

PMID25621807
OpenAlexW2009184875

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.